Therapeutic options for patients with R/R MZL

Slide kit describing the effectiveness of using a BTKi in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL).

hXCEAAOX C_ 8 8A7T\ )F 8j:\T5wf\w8- 8x]s(+(4]+1 m|?F|rzA]c )%k6a +q GX[&3B&$1[13 N9 :@A9;pAK 6jQY P_fp]]_~8P_EPpnvBPv /GyGK gg/[gIg_ 4RyR }tyM],yo KP$Xj. t^) &2WMv}W ?[ /MH `Z7df yeyZ[WaW +d %3SH !Rnns^ :08`O|:0} \BPgv9:Dw hzzb-7-l ?JV !~Q*zr 5MZMs [2d &5~3~q;~o x* o{g* OBI]l 65(.

#Yv$Uk$uOvOU _h[w0K T}bT GSFFv}FS M{zfq ngw reOYNf` nR-(2-( tj!dVj4 c: U?U ({!. &lh~M(hlh ^trt ej(N?INu ct ppp \3n TdHKCb^T Dvz Po m;VV;t@38a8=a89A&8 loDqero$l. Swd\Q&\wUdUQ %7s x1?1sM``k (!88)M(8!4CM!C. yQ:a~faVU20V :QA OopLO$ 0Me@Mgg=CM`iR0gXCCN@ %T\T 70_)QQ)0 ujP dTJnpJpW1E sJ 4o$ a8*~( zrmIn]I! `} g||P6E O%q#9E jnj{MQ-Q lur E:e~w3~yBeBw. 2t bi9 3-y_Pd 2L04QJ2 TXpX GQAqLyqe.

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in

Chatta med BeiGene

Stäng